One of the out-patient treatment alternatives for clients in West Jordan who are battling with opioid abuse and addiction is opioid maintenance therapy. Some centers and doctors are authorized to administer certain meds to opioid addicted people, many that are opioid-based also and are addiction. In low amounts the client doesn't experience being high but also does not have acute cravings and is not experiencing opioid withdrawal. Methadone is the first med tried for this sole purpose, but there are other options currently to select from.
Methadone is an opiate and can be taken at an out-patient clinic certified to dispense the drug, which is taken on a daily basis in liquid or pill form. The cost of the drug is approximately $150 a month. Buprenorphine is also an opioid based med, and is in pill form often taken every other day. But unlike Methadone that is only be given in highly well-regulated clinics, Buprenorphine can be prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is approximately just under $300 /month for the generic version of the drug. There is also a version of buprenorphine containing the drug naloxone, that is a drug which reverses the effects of opioids. Someone consuming this formulation, AKA Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced around $450 /month. Naltrexone is an additional drug used in opioid maintenance therapy, but unlike the other drugs aforementioned it is an opioid blocker and isn't an opiate. A person has the choice to take this drug as a monthly shot, and that is called Vivitrol. As an opioid blocker, the drug prevents a person from experience high feelings from opioids, and in turn lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 a month.
There are 1 Drug and Alcohol Treatment Programs offering this service in West Jordan, UT
For All Drug and Alcohol Rehabilitation Facilities In West Jordan, Click Here.